Andere talen Bausch + Lomb Corporation Toronto S.E.

Aandelen

BLCO

CA0717051076

Beurs gesloten - Toronto S.E. Andere beurzen 21:55:22 14-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
20,69 ^CAD	+1,22%		-2,04%	-8,73%

10/06	Bausch + Lomb Corporation kondigt de Amerikaanse introductie aan van Bausch + Lomb Infuse for Astigmatism dagelijks te gebruiken contactlenzen	CI
03/06	Bausch + Lomb Corporation lanceert Blink? NutriTears® klinisch bewezen voedingssupplement voor droge ogen in de Verenigde Staten	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Bausch + Lomb Corporation Announces the U.S. Introduction of Bausch + Lomb Infuse for Astigmatism Daily Disposable Contact Lenses	10/06
Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States	10/06
Bausch + Lomb Brief: Launching "Clinically Proven" Nutritional Supplement for Dry Eyes in the United States	03/06
Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States	03/06
Bausch + Lomb Corporation Launches Blink? NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States	03/06
Bausch + Lomb Corporation Approves Election of Gary Hu as Director	29/05
Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results	29/05
Bausch + Lomb Receives Health Canada Approval for enVista Envy Full Visual Range Intraocular Lens	29/05
Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry's Meeting	29/05
Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®	28/05
Bausch + Lomb's New Intraocular Lens Approved by Health Canada	28/05
Bausch + Lomb Brief: Says Received Health Canada Approval for Full Visual Range Intraocular Lens	28/05
Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens	28/05
Bausch + Lomb Corporation Receives Health Canada Approval for Envista Envy?? Full Visual Range Intraocular Lens	28/05
Bausch Health Companies - Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024	20/05
Bausch Health Announces 2024 Annual Meeting of Shareholder Results	16/05
Bausch + Lomb : 2023 Report	16/05
Bausch + Lomb Shares Rise After Morgan Stanley Upgrade	06/05
Bausch Health Announces First Quarter 2024 Results	03/05
RBC Capital Reviews Bausch + Lomb's Q1 Results	02/05

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Bausch + Lomb Corporation Toronto S.E.

Aandelen

BLCO

CA0717051076

Andere talen

Filters